Suppr超能文献

体外 CO 去除控制 COPD 急性加重期无创 NAVA 通气时的呼吸驱动。

Control of respiratory drive by extracorporeal CO removal in acute exacerbation of COPD breathing on non-invasive NAVA.

机构信息

Department of Pneumology and Critical Care Medicine, Cologne-Merheim Hospital, ARDS and ECMO Centre, Kliniken der Stadt Köln gGmbH, Witten/Herdecke University Hospital, Ostmerheimer Strasse 200, D-51109, Cologne, Germany.

Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, Canada.

出版信息

Crit Care. 2019 Apr 23;23(1):135. doi: 10.1186/s13054-019-2404-y.

Abstract

BACKGROUND

Veno-venous extracorporeal CO removal (vv-ECCOR) and non-invasive neurally adjusted ventilator assist (NIV-NAVA) are two promising techniques which may prevent complications related to prolonged invasive mechanical ventilation in patients with acute exacerbation of COPD.

METHODS

A physiological study of the electrical activity of the diaphragm (Edi) response was conducted with varying degrees of extracorporeal CO removal to control the respiratory drive in patients with severe acute exacerbation of COPD breathing on NIV-NAVA.

RESULTS

Twenty COPD patients (SAPS II 37 ± 5.6, age 57 ± 9 years) treated with vv-ECCOR and supported by NIV-NAVA were studied during stepwise weaning of vv-ECCOR. Based on dyspnea, tolerance, and blood gases, weaning from vv-ECCOR was successful in 12 and failed in eight patients. Respiratory drive (measured via the Edi) increased to 19 ± 10 μV vs. 56 ± 20 μV in the successful and unsuccessful weaning groups, respectively, resulting in all patients keeping their CO and pH values stable. Edi was the best predictor for vv-ECCOR weaning failure (ROC analysis AUC 0.95), whereas respiratory rate, rapid shallow breathing index, and tidal volume had lower predictive values. Eventually, 19 patients were discharged home, while one patient died. Mortality at 90 days and 180 days was 15 and 25%, respectively.

CONCLUSIONS

This study demonstrates for the first time the usefulness of the Edi signal to monitor and guide patients with severe acute exacerbation of COPD on vv-ECCOR and NIV-NAVA. The Edi during vv-ECCOR weaning was found to be the best predictor of tolerance to removing vv-ECCOR.

摘要

背景

静脉-静脉体外 CO 去除(vv-ECCOR)和非侵入性神经调节通气辅助(NIV-NAVA)是两种有前途的技术,它们可能预防 COPD 急性加重患者长时间接受有创机械通气相关的并发症。

方法

对接受 NIV-NAVA 通气的重度急性 COPD 发作患者进行了膈肌电活动(Edi)反应的生理研究,以通过不同程度的体外 CO 去除来控制呼吸驱动。

结果

对 20 例接受 vv-ECCOR 治疗并接受 NIV-NAVA 支持的 COPD 患者进行了研究,这些患者在逐步停止 vv-ECCOR 治疗的过程中。根据呼吸困难、耐受性和血气情况,12 例患者成功停止 vv-ECCOR 治疗,8 例患者失败。呼吸驱动(通过 Edi 测量)增加到 19±10μV(成功脱机组)和 56±20μV(失败脱机组),所有患者的 CO 和 pH 值保持稳定。Edi 是 vv-ECCOR 脱机失败的最佳预测指标(ROC 分析 AUC 为 0.95),而呼吸频率、快速浅呼吸指数和潮气量的预测价值较低。最终,19 例患者出院回家,1 例患者死亡。90 天和 180 天的死亡率分别为 15%和 25%。

结论

这项研究首次证明了 Edi 信号在监测和指导接受 vv-ECCOR 和 NIV-NAVA 治疗的重度急性 COPD 发作患者方面的有用性。在 vv-ECCOR 脱机过程中,Edi 被发现是耐受去除 vv-ECCOR 的最佳预测指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/39db/6480839/4f5fd5c3fe5e/13054_2019_2404_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验